Robert Eugene Kristal, Chief Financial Officer at BioRestorative Therapies, Inc. (BRTX), bought 7,600 shares at $5.71 ($43K) on 2022-04-08, disclosed to the SEC on 2022-04-11.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |